Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | EVP, Chief Revenue Officer | August 26, 2026 | August 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date August 26, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,720 |
Reported balance
After 2026-08-26 transaction · row 1
1 source rowRow 1 · 2026-08-26 · Sale · Disposed 165 · Balance 19,720 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2026 Filed Aug 27, 2026 20:28 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 165 | $188.49 | $31,100.85 |
DisclosureSEC source: 0001628280-26-059269 · wk-form4_1787862519.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,720 Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 20:19 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 1,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-058647 · wk-form4_1787602744.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,885 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 15:16 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 75 | $157.13 | $11,784.75 |
DisclosureSEC source: 0001628280-26-049989 · wk-form4_1785251777.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,934 Read SEC document |
| June 26, 2026 Filed Jun 27, 2026 00:47 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 75 | $152.80 | $11,460.00 |
DisclosureSEC source: 0001628280-26-045864 · wk-form4_1782521257.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,009 Read SEC document |
| May 26, 2026 Filed May 27, 2026 17:41 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 75 | $147.35 | $11,051.25 |
DisclosureSEC source: 0001628280-26-038382 · wk-form4_1779903672.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,084 Read SEC document |
| April 27, 2026 Filed Apr 28, 2026 11:44 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 74 | $151.94 | $11,243.56 |
DisclosureSEC source: 0001628280-26-027731 · wk-form4_1777376656.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,159 Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 17:49 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 75 | $156.83 | $11,762.25 |
DisclosureSEC source: 0001628280-26-021644 · wk-form4_1774633795.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,233 F1 · balance_after: This reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 7, 2025. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 22:45 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 75 | $181.84 | $13,638.00 |
DisclosureSEC source: 0001628280-26-012955 · wk-form4_1772232327.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,308 F1 · balance_after: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 14:46 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 75 | $202.73 | $15,204.75 |
DisclosureSEC source: 0001628280-26-003734 · wk-form4_1769611611.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, CRO & Pres. Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,431 Read SEC document |
| December 26, 2025 Filed Dec 29, 2025 12:00 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 74 | $196.08 | $14,509.92 |
DisclosureSEC source: 0001628280-25-058843 · wk-form4_1767009647.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, CRO & Pres. Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,506 Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 23:25 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 75 | $193.36 | $14,502.00 |
DisclosureSEC source: 0001628280-25-054855 · wk-form4_1764717914.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, CRO & Pres. Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,580 Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:06 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054349 · wk-form4_1764608782.xml · nonDerivative · entry 2 Feld Michael · CIK 0002034349 · EVP, CRO & Pres. Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,655 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:06 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 8,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054349 · wk-form4_1764608782.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, CRO & Pres. Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,074 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 15:58 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 57 | $186.01 | $10,602.57 |
DisclosureSEC source: 0001628280-25-046645 · wk-form4_1761667077.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,245 Read SEC document |
| September 26, 2025 Filed Sep 29, 2025 20:58 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 58 | $181.03 | $10,499.74 |
DisclosureSEC source: 0001628280-25-043134 · wk-form4_1759179496.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,302 Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 19:41 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 57 | $197.99 | $11,285.43 |
DisclosureSEC source: 0000010795-25-000085 · wk-form4_1756237265.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,360 Read SEC document |
| August 20, 2025 Filed Aug 22, 2025 17:26 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000010795-25-000083 · wk-form4_1755883561.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,417 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 15:00 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciated Rights · Derivative | 10,004 | $0.00 Strike: $224.25 | $0.00 |
DisclosureSEC source: 0001062993-24-019798 · form4.xml · derivative · entry 2 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,004 Underlying: Common Stock · 10,004 shares Expires 2034-11-26 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2025. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 15:00 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 2,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019798 · form4.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,190 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| August 20, 2024 Filed Aug 21, 2024 15:23 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 6,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-015500 · form4.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,637 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.